Steven A. Kriegsman

Steven A. Kriegsman has filed trades across 3 companies (mainly through SEC (Form 4)), most often in SELLAS Life Sciences Group, Inc., Bradley Pharmaceuticals Inc and Cytrx Corp. The record holds 108 filings, for trades running from 21 February 2008 to 7 August 2020.

Both buying and selling appear: 2 purchases worth €38k, against 86 sales worth €3.5M. Netting one side against the other leaves €3.5M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 4 share grants and 6 option exercises.

On 13 August 2020 came the latest disclosure, an option exercise for €657k in Cytrx Corp. The latest purchase dates back some time: it was published 5,356 days ago, on 24 February 2012. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.